Accredited
SCIE
SCOPUS
Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?
대한당뇨병학회
2024.05
This article is 4 pages or less.
* This article cannot be purchased.